
Obicetrapib slashes LDL cholesterol by over 30% in high-risk heart patients
In a global trial of over 2,500 patients, obicetrapib dramatically reduced LDL cholesterol levels when added to standard lipid-lowering therapy, offering new hope for those at highest cardiovascular risk. Study: Safety and Efficacy of Obicetrapib in …